Insider Trading activities of Tcr2 Therapeutics Inc. insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Tcr2 Therapeutics Inc. since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Tcr2 Therapeutics Inc. since year 2005. Table 2 shows the detailed insider transactions of Tcr2 Therapeutics Inc. since 2005. The reporting company's ticker symbol is TCRR. The reporting company's CIK number is 1750019.
The total value of stock buying since 2005 is $64,799,985.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $0.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Tcr2 Therapeutics Inc. (TCRR).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2019-02 4,319,999 $64,799,985 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Tcr2 Therapeutics Inc. insiders (TCRR)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2019-02-19 China Molybdenum (hong Kong) Co Ltd (10% Owner) Buy 200,000 15.00 3,000,000
2019-02-19 F2 Capital I 2019, Llc (10% Owner) Buy 666,667 15.00 10,000,005
2019-02-19 Mpm Sunstates Gp Managing Member Llc (10% Owner) Buy 706,666 15.00 10,599,990
2019-02-19 Mpm Oncology Impact Management Gp Llc (10% Owner) Buy 666,667 15.00 10,000,005
2019-02-19 Mpm Asset Management Llc (10% Owner) Buy 706,666 15.00 10,599,990
2019-02-19 Gadicke Ansbert (Director) Buy 1,373,333 15.00 20,599,995

Insider trading activities including stock purchases, stock sales, and option exercises of TCRR listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Tcr2 Therapeutics Inc. (symbol TCRR, CIK number 1750019) see the Securities and Exchange Commission (SEC) website.